Renin inhibiting peptides having an .alpha.-heteroatom amino aci

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 18, 530330, 530331, 530800, A61K 3700, C07K 500

Patent

active

052216675

ABSTRACT:
The invention concerns novel renin-inhibitory compounds which are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, glaucoma, and diseases caused by retroviruses including HTLV-I -II, and -III. Processes for preparing the compounds, novel intermediates useful in the preparation thereof, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, congestive heart failure, or hyperaldosteronism.

REFERENCES:
patent: 5036054 (1991-07-01), Kaltenbronn
Burger, Medicinal Chemistry, 1960, pp. 565-571, 578-581, 600-601.
Plattner et al. J. Med. Chem. 1988, 31(12):2277-2288.
Bolis et al. J. Med. Chem. 1987, 31(10):1729-1737.
Haber et al. J. Cardiovasc. Pharmacol. 1988, 10 (Suppl. 7):S54-S58.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Renin inhibiting peptides having an .alpha.-heteroatom amino aci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Renin inhibiting peptides having an .alpha.-heteroatom amino aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibiting peptides having an .alpha.-heteroatom amino aci will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1441076

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.